Skip to content

Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity

A Randomized Controlled Trial: Comparison of a Top Loading MESA® Spinal System With MESA Rail™ and a Side Locking Pedicle Screw System for the Treatment of Adolescent Paediatric Spine Deformity

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02590380
Enrollment
0
Registered
2015-10-29
Start date
2022-09-30
Completion date
2030-09-30
Last updated
2021-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Idiopathic Scoliosis

Keywords

Adolescent, paediatric, pediatric, scoliosis, spine deformity

Brief summary

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system.

Detailed description

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system. This is a single-center, single-surgeon randomized controlled trial with follow-up evaluations of patients conducted at initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure. Adverse events will be monitored continuously.

Interventions

DEVICEMESA Rail Deformity System

The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the MESA Rail Deformity System.

DEVICEDePuy Synthes USS II System

The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the DePuy Synthes USS II system.

Sponsors

K2M, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of Adolescent Idiopathic Scoliosis (AIS) with no associated syndrome requiring surgical treatment for selective thoracic/lumbar fusion with a minimum of five (5) instrumented vertebrae between T1-S1 as confirmed by patient history and radiographic studies. AIS cases must be classified as a Lenke type 1 or type 2 curve. No cervical vertebrae are to be incorporated into the construct. 2. Willingness and ability to comply with the requirements of the protocol including follow-up requirements. 3. Willing and able to sign a study specific informed consent form or, in the case of a patient who is a minor, provide assent and the minor patient's parent/legal guardian provides written consent to participate. 4. Age range of ≥ 11 years old and ≤ 21 years old at time of surgery.

Exclusion criteria

1. Previous anterior or posterior spine surgery at the index levels. 2. Previous posterior spine surgery (e.g., posterior element decompression) that destabilizes the cervical/thoracic/lumbar spine. 3. Active systemic infection or infection at the operative site. 4. Any sign of any spinal dysrhaphism (any cord abnormality). 5. Co-morbid medical conditions of the spine or upper/lower extremities that may affect the thoracic or lumbar spine neurological and/or pain assessment. 6. Metabolic bone disease such as osteoporosis that contradicts spinal surgery. 7. History of an osteoporotic fracture. 8. History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism. 9. Taking medications that may interfere with bony/soft tissue healing including chronic oral steroid use. 10. Known allergy to titanium or cobalt chrome. 11. Rheumatoid arthritis or other autoimmune disease or a systemic disorder such as HIV, active hepatitis B or C or fibromyalgia. 12. Insulin-dependent type 1 or type 2 diabetes. 13. Medical condition (e.g., unstable cardiac disease, cancer) that may result in patient death or have an effect on outcomes prior to study completion. 14. Pregnant, or intend to become pregnant, during the course of the study. 15. Severe obesity (Body Mass Index \> 40). 16. Physical or mental condition (e.g., psychiatric disorder, senile dementia, Alzheimer's disease, alcohol or drug addiction) that would interfere with patient self-assessment of function, pain or quality of life. 17. Incarcerated at the time of study enrollment. 18. Current participation in an investigational study that may impact study outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Correction and Maintenance of Spinal Deformity (coronal)Change from pre-operative to 3 months, 12 months and 24 months post-procedureRadiographic analysis of the spinal deformity in the coronal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.
Correction and Maintenance of Spinal Deformity (sagittal)Change from pre-operative to 3 months, 12 months and 24 months post-procedureRadiographic analysis of the spinal deformity in the sagittal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.

Secondary

MeasureTime frameDescription
Estimated Blood Volume Loss/Salvage ReturnOperative Data - to be collected immediately after case is completed. Estimated blood loss will be noted by the surgical/anesthesia team and this value can then be immediately collected.The amount of blood loss over the entire length of the surgery as well as salvage return volumes will be captured intraoperatively.
Length of Hospital StayAt discharge (up to one week post surgery) - Once the subject has been released from the hospital, the length of hospital stay can be calculated using the intake and discharge dates.The length of hospital stay from the date of admission to the date of discharge will be calculated.
Back and Leg Pain 10cm Visual Analog Scale (VAS)Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.The severity of back and leg pain will be evaluated in all study subjects using a 10-cm visual analog scale (VAS). The study will employ a 15% improvement for success. OVERALL CHANGE from baseline will be assessed at each timepoint.
Return to Sport/Physical ActivityInitial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.The ability to return to sport as performed by the individual patient pre operatively. Time to walking unaided, running, swimming, trampoline, contact sport, normal social interactions with peer group. Once the subject has returned to the baseline status this question will not be asked.
Use of Analgesia Post-SurgeryInitial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.The types and dosages of any analgesia taken by the patient post-surgery will be documented. Overall change from baseline (pre-operative medications) will be analyzed at each interval - anticipation is that use of analgesia decreases and/or ends after surgery.
Return to Work/SchoolInitial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery will be documented. Once the subject has returned to the baseline status this question will not be asked.
SRS-22Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.Scoliosis and its treatment have a great impact on the quality of life of the affected patients. The Revised Scoliosis Research Society-22 (SRS-22r) is a specific questionnaire for spine conditions. It is applied to patients with idiopathic scoliosis, whose conditions and treatments have a great impact on their quality of life. The SRS-22r was created and revised with the purpose of evaluating this impact from the patient's point of view. The reviewed version contains 22 questions distributed into five domains: function/activity (FA), pain (P), self-image/appearance (SA), mental health (MH) and satisfaction with treatment (ST). The scores vary from 1 to 5, in which 5 is the best health quality of life of patients. OVERALL CHANGE from baseline will be assessed at each timepoint.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026